ReviewInternational urology and nephrology2016
The kidney regulates regeneration, but don't upset the balance.
Review in International urology and nephrology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- Decoding the Intercellular Cross-Talking Between Immune Cells and Renal Innate Cells in Diabetic Kidney Disease by Bioinformatics.Journal of inflammation research · 2023Article
- Renal Macrophages and Dendritic Cells in SLE Nephritis.Current rheumatology reports · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Better understanding of the cellular pathophysiological process undergoing kidney injury and repair will be hopefully result in the design of more targeted therapies to prevent injury, hasten repair, and minimize chronic progressive kidney diseases. The relevance of CSF-1 signalling for kidney organ development and inflammatory disease has been highlighted by numerous studies. Interestingly, there are different functions of CSF-1 in acute kidney injury versus chronic kidney disease (CKD). Within CKD, an enhanced expression of CSF-1 results in more damage, and thus disruption of the CSF-1/CSF-1R interaction/activation is protective. A reverse scenario is seen during acute kidney injury, where inhibition of CSF-1 leads to delayed recovery of kidney function and less regenerative (M2) macrophages. However, the major factor to stimulate epithelial cell repair and the cell type(s) generating the factor in response to acute kidney injury remained unclear. In their recent report Wang et al. used a specific CSF-1 knockout in the proximal tubular cells, induced acute kidney injury, and analyzed the recovery of kidney function. They nicely demonstrated a strong positive effect of renal and proximal tubular secreted CSF-1. It mediates the differentiation of infiltrated monocytes into M2 macrophages, also denoted as reparative macrophages. Mice with a deletion of CSF-1 within the proximal tubular cells exhibited a delayed recovery from acute kidney injury. These findings may pave the path to therapeutic intervention in acute kidney injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.